SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-20-000290
Filing Date
2020-08-19
Accepted
2020-08-19 17:24:45
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 skvi10q.htm 10-Q 438622
2 GRAPHIC image_001.jpg GRAPHIC 8053
3 ex31_1.htm EX-31.1 9073
4 ex31_2.htm EX-31.2 8991
5 ex32_1.htm EX-32.1 4120
  Complete submission text file 0001663577-20-000290.txt   2522572

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE skvi-20200630.xml EX-101.INS 400208
7 XBRL SCHEMA FILE skvi-20200630.xsd EX-101.SCH 24678
8 XBRL CALCULATION FILE skvi-20200630_cal.xml EX-101.CAL 29287
9 XBRL DEFINITION FILE skvi-20200630_def.xml EX-101.DEF 66896
10 XBRL LABEL FILE skvi-20200630_lab.xml EX-101.LAB 194183
11 XBRL PRESENTATION FILE skvi-20200630_pre.xml EX-101.PRE 184401
Mailing Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120 7024337154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

IRS No.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25911 | Film No.: 201117889
SIC: 2834 Pharmaceutical Preparations